Osteogenix: Innovating bone repair and growth therapies since 2005 with a skilled team of experts.
Founded in 2005, Osteogenix is a therapeutic products company dedicated to developing and commercializing innovative solutions for bone repair and growth. The company's core mission is to advance the osteo-pharmacologic platform discovered and patented by Dr. Mundy and his team. Osteogenix focuses on creating novel products to address the large and rapidly expanding market for bone therapeutics, aiming to improve patient outcomes through cutting-edge research and development.
Osteogenix has assembled a distinguished team of expert advisors, including many who have served as principal investigators in key orthobiologics trials. This collaboration has led to significant advancements in their field, positioning Osteogenix as a leader in bone therapeutics. The company's impact is marked by its commitment to pioneering new treatments that enhance bone healing and growth, contributing to the broader medical community's efforts to address complex bone-related conditions.

Bone Biologics
bonebiologics.com

OssiFi
ossifi.com

Zetagen Therapeutics
zetagen.com

OsteoNovus
osteonovus.com
Osteomimetics

Nostopharma
nostopharma.com

CelgenTek

Osteal Therapeutics
ostealtx.com

Beryl Therapeutics

AgNovos Healthcare
agnovos.com

Bone Solutions
bonesolutions.net

Progenerative Medical
progenerative.com

Genascence
genascence.com
Audax Medical
audaxmed.com
Tissue Regeneration Systems
tissuesys.com

Molecular Matrix

Histogen
histogen.com

DiscGenics
discgenics.com
OmegaGenesis

Bone-Rad Therapeutics
bone-rad.com
Osteogenix's most recent funding round was for $1.2M (USD) in December 2010.
As of Dec 31, 2010, Osteogenix has disclosed funding of $1.8M (USD).